Schrödinger Expands Board of Directors with Appointment of Bridget van Kralingen
Schrödinger (Nasdaq: SDGR) has appointed Bridget van Kralingen to its Board of Directors, effective March 7, 2025. Van Kralingen brings over 35 years of experience in global technology and software business leadership. She currently serves as a senior partner at Motive Partners, an investment firm focused on technology-enabled companies.
Prior to her current role, van Kralingen spent nearly 18 years at IBM, most recently as chief executive/senior vice president of IBM Global Markets, where she managed $80 billion in revenue and profit. She previously led IBM's Industry Platforms software division and served as a managing partner at Deloitte Consulting for 15 years.
Van Kralingen currently holds board positions at Teradyne, IEX Group, Travelers Companies, and Discovery
Schrödinger (Nasdaq: SDGR) ha nominato Bridget van Kralingen nel suo Consiglio di Amministrazione, con effetto dal 7 marzo 2025. Van Kralingen porta con sé oltre 35 anni di esperienza nella leadership nel settore tecnologico e del software a livello globale. Attualmente ricopre il ruolo di partner senior presso Motive Partners, una società di investimento focalizzata su aziende abilitate dalla tecnologia.
Prima della sua attuale posizione, van Kralingen ha trascorso quasi 18 anni in IBM, più recentemente come amministratore delegato/vicepresidente senior di IBM Global Markets, dove ha gestito 80 miliardi di dollari in entrate e profitti. In precedenza, ha guidato la divisione software Industry Platforms di IBM e ha ricoperto il ruolo di partner dirigente presso Deloitte Consulting per 15 anni.
Van Kralingen attualmente ricopre posizioni nel consiglio di amministrazione di Teradyne, IEX Group, Travelers Companies e Discovery.
Schrödinger (Nasdaq: SDGR) ha nombrado a Bridget van Kralingen en su Junta Directiva, con efecto a partir del 7 de marzo de 2025. Van Kralingen aporta más de 35 años de experiencia en liderazgo empresarial en tecnología y software a nivel global. Actualmente, es socia senior en Motive Partners, una firma de inversión centrada en empresas habilitadas por la tecnología.
Antes de su cargo actual, van Kralingen pasó casi 18 años en IBM, más recientemente como directora ejecutiva/vicepresidenta senior de IBM Global Markets, donde gestionó 80 mil millones de dólares en ingresos y beneficios. Anteriormente, lideró la división de software Industry Platforms de IBM y fue socia gerente en Deloitte Consulting durante 15 años.
Van Kralingen ocupa actualmente puestos en la junta de Teradyne, IEX Group, Travelers Companies y Discovery.
슈뢰딩거 (Nasdaq: SDGR)는 브리짓 반 크랄린겐을 이사로 임명했으며, 이는 2025년 3월 7일부터 효력이 발생합니다. 반 크랄린겐은 글로벌 기술 및 소프트웨어 비즈니스 리더십에서 35년 이상의 경험을 가지고 있습니다. 현재 그녀는 기술 기반 기업에 중점을 둔 투자 회사인 모티브 파트너스의 수석 파트너로 활동하고 있습니다.
현재 역할 이전에, 반 크랄린겐은 IBM에서 거의 18년을 보냈으며, 최근에는 IBM 글로벌 마켓의 CEO/수석 부사장으로 재직하면서 800억 달러의 수익과 이익을 관리했습니다. 그녀는 이전에 IBM의 산업 플랫폼 소프트웨어 부서를 이끌었으며, 15년 동안 딜로이트 컨설팅의 관리 파트너로 근무했습니다.
반 크랄린겐은 현재 테라다인, IEX 그룹, 트래블러스 컴퍼니즈 및 디스커버리의 이사회 직책을 맡고 있습니다.
Schrödinger (Nasdaq: SDGR) a nommé Bridget van Kralingen au sein de son Conseil d'Administration, à compter du 7 mars 2025. Van Kralingen apporte plus de 35 ans d'expérience dans le leadership des entreprises technologiques et des logiciels à l'échelle mondiale. Elle occupe actuellement le poste de partenaire senior chez Motive Partners, une société d'investissement axée sur les entreprises habilitées par la technologie.
Avant son poste actuel, van Kralingen a passé près de 18 ans chez IBM, plus récemment en tant que directrice générale/vice-présidente senior des marchés mondiaux d'IBM, où elle a géré 80 milliards de dollars de revenus et de bénéfices. Elle a précédemment dirigé la division des logiciels des plateformes industrielles d'IBM et a été partenaire gérante chez Deloitte Consulting pendant 15 ans.
Van Kralingen occupe actuellement des postes au conseil d'administration de Teradyne, IEX Group, Travelers Companies et Discovery.
Schrödinger (Nasdaq: SDGR) hat Bridget van Kralingen in seinen Vorstand berufen, mit Wirkung zum 7. März 2025. Van Kralingen bringt über 35 Jahre Erfahrung in der Führung von globalen Technologie- und Softwareunternehmen mit. Derzeit ist sie Senior Partnerin bei Motive Partners, einer Investmentfirma, die sich auf technologiegestützte Unternehmen spezialisiert hat.
Vor ihrer aktuellen Rolle verbrachte van Kralingen fast 18 Jahre bei IBM, zuletzt als Chief Executive/Senior Vice President von IBM Global Markets, wo sie 80 Milliarden Dollar an Einnahmen und Gewinnen verwaltete. Zuvor leitete sie die Software-Abteilung für Branchenplattformen von IBM und war 15 Jahre lang Managing Partner bei Deloitte Consulting.
Van Kralingen hat derzeit Vorstandspositionen bei Teradyne, IEX Group, Travelers Companies und Discovery inne.
- Addition of experienced board member with proven track record in growing global software businesses
- New director brings extensive executive experience managing $80 billion revenue operation at IBM
- Strategic appointment adds expertise in technology solutions and software business development
- None.
Bridget van Kralingen was appointed to Schrödinger’s Board of Directors in March 2025. (Photo: Business Wire)
“Bridget has a proven track record of growing global software businesses, and we are pleased to welcome her to our Board,” said Ramy Farid, Ph.D., chief executive officer of Schrödinger. “Bridget’s leadership experience overseeing strategic initiatives at global technology companies, including IBM, will be valuable to Schrödinger as we continue to advance our computational platform and are positioned for long-term success.”
Ms. van Kralingen brings more than 35 years of experience leading and growing global technology solution and software businesses and is currently a senior partner at Motive Partners, an investment firm focused on technology-enabled companies. Prior to Motive Partners, Ms. van Kralingen spent nearly 18 years in a variety of chief executive roles at IBM. She most recently served as chief executive/senior vice president of IBM Global Markets, where she was responsible for IBM’s
“I’m honored to join Schrödinger’s Board of Directors at this exciting time in the company’s evolution,” said Bridget van Kralingen. “Schrödinger is at the forefront of revolutionizing medicines and materials discovery, and I look forward to contributing to the company’s continued growth and success."
About Schrödinger
Schrödinger is transforming molecular discovery with its computational platform, which enables the discovery of novel, highly optimized molecules for drug development and materials design. Schrödinger’s software platform is built on more than 30 years of R&D investment and is licensed by biotechnology, pharmaceutical and industrial companies, and academic institutions around the world. Schrödinger also leverages the platform to advance a portfolio of collaborative and proprietary programs and is advancing three clinical-stage oncology programs. Founded in 1990, Schrödinger has approximately 900 employees operating from 15 locations globally. To learn more, visit www.schrodinger.com, follow us on LinkedIn and Instagram, or visit our blog, Extrapolations.com.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 including, but not limited to those regarding our expectations about the benefits of our computational platform, and our strategic plans to accelerate the growth of our software licensing business and advance our collaborative and proprietary drug discovery programs. Statements including words such as “aim,” "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," “goal,” "intend," "may," "might," "plan," "potential," "predict," "project," "should," "target," "will," "would" and statements in the future tense are forward-looking statements. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Actual results may differ materially from those described in the forward-looking statements and are subject to a variety of assumptions, uncertainties, risks and factors that are beyond our control, including the demand for our software platform, our ability to further develop our computational platform, the ability to retain and hire key personnel and other risks detailed under the caption "Risk Factors" and elsewhere in our Securities and Exchange Commission filings and reports, including the Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the Securities and Exchange Commission on February 26, 2025, as well as future filings and reports by us. Any forward-looking statements contained in this press release speak only as of the date hereof. Except as required by law, we undertake no duty or obligation to update any forward-looking statements contained in this press release as a result of new information, future events, changes in expectations or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250310010062/en/
Matthew Luchini (Investors)
matthew.luchini@schrodinger.com
917-719-0636
Allie Nicodemo (Media)
allie.nicodemo@schrodinger.com
617-356-2325
Source: Schrödinger
FAQ
When will Bridget van Kralingen join Schrödinger's (SDGR) Board of Directors?
What was Bridget van Kralingen's most recent role at IBM before joining SDGR's board?
How many years of experience does the new SDGR board member have in technology and software business?
What other board positions does Schrödinger's new director currently hold?
